Medicamen Biotech Ltd

medicamen.com BSE: 531146
About [ edit ]

Medicamen Biotech is in the manufacture of Pharmaceuticals formulations products.

Website BSE
  • Market Cap ₹ 641 Cr.
  • Current Price ₹ 524
  • High / Low ₹ 665 / 214
  • Stock P/E 65.4
  • Book Value ₹ 105
  • Dividend Yield 0.10 %
  • ROCE 15.1 %
  • ROE 11.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 94.67% CAGR over last 5 years

Cons

  • The company has delivered a poor sales growth of 8.57% over past five years.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
29.30 32.76 32.49 24.08 24.08 31.13 35.52 35.33 15.36 26.12 30.77 32.92
25.52 28.54 28.36 19.70 19.70 26.12 29.82 29.89 13.75 22.21 25.22 27.66
Operating Profit 3.78 4.22 4.13 4.38 4.38 5.01 5.70 5.44 1.61 3.91 5.55 5.26
OPM % 12.90% 12.88% 12.71% 18.19% 18.19% 16.09% 16.05% 15.40% 10.48% 14.97% 18.04% 15.98%
Other Income 1.00 1.16 1.81 0.07 0.07 0.04 0.35 0.45 1.07 0.08 0.13 0.00
Interest 0.51 0.36 0.35 0.20 0.20 0.16 0.21 0.19 0.00 0.24 0.38 0.09
Depreciation 0.50 0.48 0.48 0.59 0.59 0.57 0.62 0.64 0.67 0.69 0.70 0.71
Profit before tax 3.77 4.54 5.11 3.66 3.66 4.32 5.22 5.06 2.01 3.06 4.60 4.46
Tax % 50.66% 29.07% 30.33% 34.15% 34.15% 24.07% 26.44% 27.27% 27.36% 30.72% 30.00% 32.29%
Net Profit 1.86 3.22 3.56 2.40 2.40 3.28 3.84 3.68 1.46 2.10 3.22 3.01
EPS in Rs 1.64 2.75 3.04 2.05 2.05 2.68 3.14 3.01 1.20 1.72 2.64 2.46
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
86 102 123 101 64 73 78 67 82 112 123 117 105
82 94 117 98 64 68 73 62 71 95 105 99 89
Operating Profit 5 8 6 3 -0 5 5 6 12 17 17 18 16
OPM % 5% 8% 5% 3% -0% 7% 6% 8% 14% 15% 14% 15% 16%
Other Income 0 1 1 1 1 1 1 1 0 2 4 2 1
Interest 2 2 2 3 4 4 4 4 4 3 1 1 1
Depreciation 1 1 1 2 2 2 2 2 2 2 2 2 3
Profit before tax 2 6 4 -1 -5 0 0 1 6 14 18 17 14
Tax % 22% 33% 36% -28% -1% 44% -267% 32% 19% 27% 31% 26%
Net Profit 1 4 3 -1 -5 0 0 0 5 10 12 12 10
EPS in Rs 3.52 -1.01 -5.81 0.10 0.46 0.48 4.91 8.89 10.28 10.04 8.02
Dividend Payout % 0% 15% 0% 0% 0% 0% 0% 0% 0% 12% 10% 5%
Compounded Sales Growth
10 Years:1%
5 Years:9%
3 Years:12%
TTM:-17%
Compounded Profit Growth
10 Years:12%
5 Years:95%
3 Years:34%
TTM:-26%
Stock Price CAGR
10 Years:36%
5 Years:42%
3 Years:-8%
1 Year:115%
Return on Equity
10 Years:10%
5 Years:15%
3 Years:15%
Last Year:12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions
Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
8 8 8 8 8 9 10 10 11 12 12 12 12
Reserves 5 9 12 11 7 7 7 8 15 63 75 110 116
Borrowings 9 13 10 14 17 15 21 19 18 14 12 11 18
24 29 40 35 33 33 31 23 30 28 38 43 34
Total Liabilities 46 58 70 69 65 65 69 60 73 118 137 176 180
18 20 23 23 23 22 20 19 19 25 24 34 36
CWIP 0 1 0 0 0 1 0 0 0 0 15 40 47
Investments 0 0 0 0 0 0 0 0 0 0 0 2 2
27 37 47 46 42 42 49 41 54 92 97 100 95
Total Assets 46 58 70 69 65 65 69 60 73 118 137 176 180

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
8 1 11 -3 -2 5 -3 6 4 -5 4 12
-2 -3 -4 -1 -1 -1 0 -1 -2 -8 -15 -39
-6 3 -4 3 2 -4 3 -5 -1 33 -4 21
Net Cash Flow 0 0 4 -2 -1 1 -0 0 0 20 -14 -6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 16% 30% 22% 6% -3% 13% 12% 12% 25% 25% 20% 15%
Debtor Days 63 81 65 86 105 102 124 87 114 126 129 137
Inventory Turnover 8.63 9.18 7.10 6.09 3.43 3.72 4.19 3.70 4.14 5.03 5.80 4.71

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
46.02 46.02 44.53 44.53 44.77 44.77 44.77 44.77 44.77 44.77 44.77 44.83
0.49 0.49 0.49 0.49 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.44
53.49 53.49 54.99 54.99 54.76 54.76 54.76 54.76 54.76 54.76 54.76 54.73

Documents

Recent announcements


View all

Annual reports

Credit ratings